Skip to main content
. 2023 Dec 27;29(2):e280–e287. doi: 10.4317/medoral.26264

Table 2. The 15 studies that evaluated the systemic therapies for advanced salivary gland carcinomas and their administration route, responses, and most toxicities.

graphic file with name medoral-29-e280-t002.jpg